Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma

LAG-3 is one of the common tumor immune checkpoints. LAG-3 can inhibit the activation and proliferation of T cells, and can also suppress immunity by regulating other immune-related cell functions. FGL1 was recently discovered to be the main ligand of immune checkpoint LAG-3 and play a critical role...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Qing, Lin, Hao-Ming, Zhu, Ke, Cao, Yi, Xu, Xiao-Lin, Zhou, Zi-Yu, Xu, Lei-bo, Liu, Chao, Zhang, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901582/
https://www.ncbi.nlm.nih.gov/pubmed/35273912
http://dx.doi.org/10.3389/fonc.2022.810269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901582/
https://www.ncbi.nlm.nih.gov/pubmed/35273912
http://dx.doi.org/10.3389/fonc.2022.810269

Ejemplares similares